Stryker, a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons’ (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics.
With the introduction of Mako Total Hip with Advanced Primary and Revision, Stryker expands on its established Mako Total Hip offering to include a first-to-market robotic hip revision capability. In revision total hip arthroplasty (THA), the expanded Mako Total Hip application is engineered to streamline workflow and enable confidence in challenging procedures with new features such as augment and screw planning, intraoperative screw trajectory guidance and compatibility with Stryker’s revision hip implant portfolio. These new capabilities are designed to help surgeons simplify hip procedures by knowing more with Mako’s 3D CT-based planning, now across both primary and revision THA procedures.
Additionally, now commercially available is Stryker’s fourth generation Mako System, Mako 4, a single robotics system that delivers additional applications and innovation, designed to offer a premium clinical and operational experience compared to manual across Mako Total Hip, Total Knee, Partial Knee and Spine. Mako 4 also integrates Stryker’s fourth-generation Q Guidance System, which is built on over 20 years of experience developing guidance technologies.
“Today’s advancements in Mako SmartRobotics build on a foundation of clinical impact, innovation and market leadership,” said Keith Evans, Vice President and General Manager of Stryker’s Mako and Enabling Technologies business. “We are thrilled to showcase and demonstrate the future of Mako, not only what it can do but who it serves – more surgeons, more patients, across more specialties and more procedures.”
